
3PO (b)
CAS No. 13309-08-5
3PO (b) ( —— )
产品货号. M11318 CAS No. 13309-08-5
PFKFB3(6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶)抑制剂,减少糖酵解通量并抑制葡萄糖摄取。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥324 | 有现货 |
![]() ![]() |
5MG | ¥494 | 有现货 |
![]() ![]() |
10MG | ¥689 | 有现货 |
![]() ![]() |
25MG | ¥1337 | 有现货 |
![]() ![]() |
50MG | ¥2414 | 有现货 |
![]() ![]() |
100MG | ¥4350 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称3PO (b)
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PFKFB3(6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶)抑制剂,减少糖酵解通量并抑制葡萄糖摄取。
-
产品描述PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) inhibitor, reduces glycolytic flux and suppresses glucose uptake. Inhibits endothelial cell proliferation and causes G2/M cell cycle arrest in vitro. Attenuates vessel sprouting and tumor growth in vivo. Amplifies the antiangiogenic effect of VEGFR blockade.3PO may be useful agents in combination with other drugs that inhibit Y cell proliferation. PFKFB3 inhibitors suppress glucose uptake, which in turn causes an increase in autophagy. The addition of selective inhibitors of autophagy to 3PO and its more potent derivatives may prove useful as rational combinations for the treatment of Y.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Glucokinase
-
受体PFKFB3
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number13309-08-5
-
分子量210.23
-
分子式C13H10N2O
-
纯度>98% (HPLC)
-
溶解度DMSO: > 10 mM
-
SMILESC1=CC(=CN=C1)/C=C/C(=O)C2=CC=NC=C2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Clem B, et al. Mol Y Ther. 2008 Jan;7(1):110-20.?